SubQ COVID Antibodies (Super Speedy)

* At the time of the creation of this video, the COVID-19 monoclonal antibodies were considered to be effective prior to the Omicron variant spread. It is now no longer authorized for treatment given the prevalence of Omicron as the overwhelming variant and a lack of data supporting the use of casirivimab/imdevimab injections/infusions for COVID-19 patients * 

To learn more check out our Basic Level Video! 

This is a research review. It is not meant to diagnose or treat disease. For all things medical contact your healthcare professional. This video is meant for educational purposes only. It reviews a new research paper you can find here.